Premium
IMPLICATIONS OF PHENOTHIAZINE SIDE EFFECTS: A STUDY OF ANTIPARKINSONIAN AGENTS IN AN OLDER POPULATION
Author(s) -
Martin I. C. A.
Publication year - 1975
Publication title -
acta psychiatrica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.849
H-Index - 146
eISSN - 1600-0447
pISSN - 0001-690X
DOI - 10.1111/j.1600-0447.1975.tb00220.x
Subject(s) - phenothiazine , parkinsonism , psychotropic agent , medicine , schizophrenia (object oriented programming) , population , affect (linguistics) , psychiatry , psychology , disease , environmental health , communication
A study of anti‐Parkinsonism agents in prolonged phenothiazine therapy seeks to clarify some anecdotal misconceptions. Antiparkinsonian agents do not appear to affect the therapeutic efficiency of phenothiazines, nor does using them on a “demand” basis increase the problems of control of parkinsonian side effects. Older patients, however, appear to require the extended usage of antiparkinsonian agents rather more than some studies would suggest. Sustained release antiparkinsonian agents may yet further simplify the management of schizophrenia.